Joshua Makower Insider Profile
4 Followers
Joshua Makower, Ten Percent Owner at Monte Rosa Therapeutics, holds 7.69M shares in Monte Rosa Therapeutics (Ticker: GLUE), holds 182.44M shares in NeueHealth Inc (Ticker: NEUE), holds 4.52M shares in Eargo (Ticker: EAR).
Joshua Makower's Trading History
| NEUENeueHealth Inc | Jun 30, 2021 | ― | Uninformative Buy | ― | $1.23B | |
| GLUEMonte Rosa Therapeutics | Jun 30, 2021 | Ten Percent Owner | Uninformative Buy | ― | $70.46M | |
| EAREargo | May 26, 2021 | ― | Uninformative Sell | ― | $11.62M | |
| MTCRMetacrine | Sep 22, 2020 | ― | Uninformative Buy | ― | $1.78M | |
| INZYInozyme Pharma | Jul 28, 2020 | ― | Uninformative Buy | ― | $9.75M | |
| GNCAQGenocea Biosciences | Jul 28, 2020 | ― | Informative Buy | 7.09M | ― | |
| NKTXNkarta | Jul 16, 2020 | Ten Percent Owner | Uninformative Buy | ― | $3.51M | |
| AKUSAKOUOS | Jul 01, 2020 | ― | Uninformative Buy | ― | $57.07M | |
| AVEOAVEO Pharma | Jun 22, 2020 | ― | Informative Buy | 7.50M | $59.29M | |
| TRVITrevi Therapeutics | Apr 13, 2020 | Ten Percent Owner | Uninformative Buy | 1.50K | $78.92M | |
| ARDXArdelyx | Dec 09, 2019 | Ten Percent Owner | Uninformative Buy | 2.50M | $20.15M | |
| MIRMMirum Pharmaceuticals | Jul 24, 2019 | Ten Percent Owner | Uninformative Buy | ― | $383.38M | |
| RGLSRegulus | May 09, 2019 | ― | Informative Buy | 1.23M | $16.75M | |
| CASCCascadian Therapeutics | Mar 13, 2018 | ― | Uninformative Sell | ― | $0.00 | |
| ORKAOruka Therapeutics | Feb 27, 2018 | Ten Percent Owner | Informative Sell | 730.10K | $0.00 | |
| AKAOQAchaogen | Dec 19, 2016 | ― | Informative Buy | 6.75M | $117.88K |
You May Also Like
Joshua Makower insider profile FAQ
What is the percentage of profitable transactions made by Joshua Makower?
The percentage of profitable transactions made by Joshua Makower is 21%.
What is the average return per transaction made by Joshua Makower?
The average return per transaction made by Joshua Makower is -16.20%.
What stocks does Joshua Makower hold?
Joshua Makower holds: GLUE, ORKA, AVEO, CASC, RGLS, GNCAQ, AKAOQ, ARDX, TRVI, MIRM, AKUS, NKTX, INZY, MTCR, EAR, NEUE stocks.
What was Joshua Makower's most profitable transaction?
Joshua Makower’s most profitable transaction was an Informative Buy of AKAOQ stock on June 7, 2016. The return on the trade was 423.70%.
What is Joshua Makower's role in Monte Rosa Therapeutics?
Joshua Makower's role in Monte Rosa Therapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
